238 related articles for article (PubMed ID: 14989736)
1. Unique cell membrane expression of topoisomerase-II alpha as a useful diagnostic marker of liposarcoma.
Endo H; Hirokawa M; Ishimaru N; Tanaka Y; Yamashita M; Sakaki M; Hayashi Y; Sano T
Pathol Int; 2004 Mar; 54(3):145-50. PubMed ID: 14989736
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.
Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A
Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690
[TBL] [Abstract][Full Text] [Related]
3. Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas.
Bauman ME; Holden JA; Brown KA; Harker WG; Perkins SL
Mod Pathol; 1997 Mar; 10(3):168-75. PubMed ID: 9071722
[TBL] [Abstract][Full Text] [Related]
4. DNA topoisomerase II-alpha as a proliferation marker in astrocytic neoplasms of the central nervous system: correlation with MIB1 expression and patient survival.
Holden JA; Townsend JJ
Mod Pathol; 1999 Dec; 12(12):1094-100. PubMed ID: 10619260
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase II-alpha expression in different cell cycle phases in fresh human breast carcinomas.
Villman K; Ståhl E; Liljegren G; Tidefelt U; Karlsson MG
Mod Pathol; 2002 May; 15(5):486-91. PubMed ID: 12011253
[TBL] [Abstract][Full Text] [Related]
6. Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon.
Staley BE; Samowitz WS; Bronstein IB; Holden JA
Mod Pathol; 1999 Apr; 12(4):356-61. PubMed ID: 10229499
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
Mattila R; Alanen K; Syrjänen S
Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
[TBL] [Abstract][Full Text] [Related]
8. Expression of human DNA Topoisomerase II-alpha in squamous cell carcinoma of the larynx and its correlation with clinicopathologic variables.
Shvero J; Koren R; Shvili I; Yaniv E; Sadov R; Hadar T
Am J Clin Pathol; 2008 Dec; 130(6):934-9. PubMed ID: 19019771
[TBL] [Abstract][Full Text] [Related]
9. Significance of cell proliferation markers (Minichromosome maintenance protein 7, topoisomerase IIalpha and Ki-67) in cavital fluid cytology: can we differentiate reactive mesothelial cells from malignant cells?
Kimura F; Kawamura J; Watanabe J; Kamoshida S; Kawai K; Okayasu I; Kuwao S
Diagn Cytopathol; 2010 Mar; 38(3):161-7. PubMed ID: 19821496
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of DNA topoisomerase II in human gastric disorders.
Yabuki N; Sasano H; Kato K; Ohara S; Toyota T; Nagura H; Miyaike M; Nozaki N; Kikuchi A
Am J Pathol; 1996 Sep; 149(3):997-1007. PubMed ID: 8780403
[TBL] [Abstract][Full Text] [Related]
11. DNA topoisomerase IIalpha in multiple myeloma: a marker of cell proliferation and not drug resistance.
Wilson CS; Medeiros LJ; Lai R; Butch AW; McCourty A; Kelly K; Brynes RK
Mod Pathol; 2001 Sep; 14(9):886-91. PubMed ID: 11557785
[TBL] [Abstract][Full Text] [Related]
12. Topoisomerase II alpha expression in breast ductal invasive carcinomas and correlation with clinicopathological variables.
Kalogeraki A; Ieromonachou P; Kafousi M; Giannikaki E; Vrekoussis T; Zoras O; Tsiftsis D; Delides G; Stathopoulos E
In Vivo; 2005; 19(5):837-40. PubMed ID: 16097435
[TBL] [Abstract][Full Text] [Related]
13. Subconjunctival herniated orbital fat: A benign adipocytic lesion that may mimic pleomorphic lipoma and atypical lipomatous tumor.
Schmack I; Patel RM; Folpe AL; Wojno T; Zaldivar RA; Balzer B; Kang SJ; Weiss SW; Grossniklaus HE
Am J Surg Pathol; 2007 Feb; 31(2):193-8. PubMed ID: 17255763
[TBL] [Abstract][Full Text] [Related]
14. DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas.
Iino K; Sasano H; Yabuki N; Oki Y; Kikuchi A; Yoshimi T; Nagura H
Mod Pathol; 1997 Sep; 10(9):901-7. PubMed ID: 9310953
[TBL] [Abstract][Full Text] [Related]
15. Expression and relationship between topoisomerase I and II alpha genes in tumor and normal tissues in esophageal, gastric and colon cancers.
Kim R; Ohi Y; Inoue H; Toge T
Anticancer Res; 1999; 19(6B):5393-8. PubMed ID: 10697567
[TBL] [Abstract][Full Text] [Related]
16. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.
Wolfsberger S; Wunderer J; Zachenhofer I; Czech T; Böcher-Schwarz HG; Hainfellner J; Knosp E
Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805
[TBL] [Abstract][Full Text] [Related]
17. Comparative topoisomerase IIa and ki 67 protein expression in papillary thyroid carcinoma based on tissue microarrays and image analysis.
Manaios L; Tsiambas E; Alevizaki M; Karameris A; Alexopoulou D; Lambropoulou S; Moreas H; Kravvaritis C; Fotiades PP; Goula K; Patsouris E; Athanassiou AE; Koutras D; Katsilambros N
J BUON; 2008; 13(4):537-41. PubMed ID: 19145676
[TBL] [Abstract][Full Text] [Related]
18. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
[TBL] [Abstract][Full Text] [Related]
19. Well-differentiated liposarcoma (atypical lipomatous tumors).
Laurino L; Furlanetto A; Orvieto E; Dei Tos AP
Semin Diagn Pathol; 2001 Nov; 18(4):258-62. PubMed ID: 11757865
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of Topoisomerase II in female breast cancer.
Koren R; Rath-Wolfson L; Ram E; Itzhac OB; Schachter B; Klein B; Gal R; Dreznik Z
Oncol Rep; 2004 Oct; 12(4):915-9. PubMed ID: 15375522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]